Prognostic value of risk stratification using blood biochemical parameters in Japanese patients with metastatic renal cell carcinoma treated by nivolumab

被引:0
|
作者
Yamamoto, Yoshiaki
Matsuyama, Hideyasu
Matsumoto, Hiroaki
Sakano, Shigeru
Fujii, Nakanori
Oba, Kazuo
Yamamoto, Mitsutaka
Kamiryo, Yoriaki
Hiragino, Takeshi
Nagao, Kazuhiro
Takai, Kimio
Aoki, Akihiko
Yoshihiro, Satoru
Tsukamoto, Manabu
Akao, Jumpei
Kitahara, Seiji
Misumi, Taku
Komatsu, Hirotaka
Oka, Shintaro
Suga, Akinobu
机构
[1] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi, Japan
[2] Yamaguchi Univ, Ube, Yamaguchi, Japan
[3] Kokura Mem Hosp, Dept Urol, Kitakyushu, Japan
[4] Tokuyama Cent Hosp, Dept Urol & Nephrol, Shunan, Japan
[5] Saiseikai Yamaguchi Gen Hosp, Dept Urol, Yamaguchi, Japan
[6] Yamaguchi Grand Med Ctr, Dept Urol, Hofu, Japan
[7] Shimonoseki Saisekai Toyoura Hosp, Dept Urol, Shimonoseki, Yamaguchi, Japan
[8] Nagato Gen Hosp, Dept Urol, Nagato, Japan
[9] Shuto Gen Hosp, Yanai, Japan
[10] Saiseikai Shimonoseki Gen Hosp, Dept Urol, Shimonoseki, Yamaguchi, Japan
[11] Masuda Red Cross Hosp, Dept Urol, Masuda, Japan
[12] Shimonoseki City Hosp, Dept Urol, Shimonoseki, Yamaguchi, Japan
[13] Yamaguchi Red Cross Hosp, Dept Urol, Yamaguchi, Japan
[14] Ogori Daiichi Gen Hosp, Yamaguchi, Japan
[15] Sanyo Onoda Municipal Hosp, Sanyo Onoda, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
724
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab
    Brown, Landon C.
    Desai, Kunal
    Wei, Wei
    Kinsey, Emily N.
    Kao, Chester
    George, Daniel J.
    Rini, Brian, I
    Ornstein, Moshe C.
    Zhang, Tian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (09)
  • [42] Outcomes and patterns of disease progression in metastatic renal cell carcinoma patients treated with nivolumab.
    Zahoor, Haris
    Barata, Pedro C.
    Allman, Kimberly D.
    Martin, Allison
    Ornstein, Moshe Chaim
    Grivas, Petros
    Gilligan, Timothy D.
    Garcia, Jorge A.
    Rini, Brian I.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [43] Analysis of Spatial Heterogeneity of Responses in Metastatic Sites in Renal Cell Carcinoma Patients Treated with Nivolumab
    Jajodia, Ankush
    Goel, Varun
    Patnaik, Nivedita
    Pasricha, Sunil
    Gupta, Gurudutt
    Batra, Ullas
    Talwar, Vineet
    TOMOGRAPHY, 2022, 8 (03) : 1363 - 1373
  • [44] Pseudoprogression and Mixed Responses in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab: A Retrospective Analysis
    Haaker, Lorenz
    Baldewijns, Marcella
    De Wever, Liesbeth
    Albersen, Maarten
    Debruyne, Philip R.
    Wynendaele, Wim
    De Meerleer, Gert
    Beuselinck, Benoit
    CLINICAL GENITOURINARY CANCER, 2023, 21 (04) : 442 - 451
  • [45] Prognostic Value of Angiopoietin-2 for Death Risk Stratification in Patients with Metastatic Colorectal Carcinoma
    Jary, Marine
    Vernerey, Dewi
    Lecomte, Thierry
    Dobi, Erion
    Ghiringhelli, Francois
    Monnien, Franck
    Godet, Yann
    Kim, Stefano
    Bouche, Olivier
    Fratte, Serge
    Goncalves, Anthony
    Leger, Julie
    Queiroz, Lise
    Adotevi, Olivier
    Bonnetain, Franck
    Borg, Christophe
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (03) : 603 - 612
  • [46] Risk stratification and treatment algorithm for metastatic renal cell carcinoma
    Foller, Susan
    Leucht, Katharina
    Grimm, Marc-Oliver
    ONKOLOGE, 2022, 28 (02): : 167 - 178
  • [47] Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma
    Grimm, Marc-Oliver
    Leucht, Katharina
    Foller, Susan
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
  • [48] The value of pretreatment clinical and biochemical parameters in staging and prognostic stratification of patients with newly diagnosed prostate carcinoma
    Stokkel, MPM
    Zwinderman, AH
    Zwartendijk, J
    Pauwels, EKJ
    Van Eck-Smit, BLF
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1998, 13 (02): : 70 - 76
  • [49] METASTATIC RISK STRATIFICATION OF CLEAR CELL RENAL CELL CARCINOMA PATIENTS BASED ON A GENOMIC SCORE
    Grimm, Julia
    Janssen, MArtin
    Wagenpfeil, Stefan
    Hartmann, Arndt
    Stoehr, Christine
    Keck, Bastian
    Kahlmeyer, Andreas
    Stoeckle, Michael
    Junker, Kerstin
    JOURNAL OF UROLOGY, 2018, 199 (04): : E358 - E358
  • [50] Metastatic risk stratification of clear cell renal cell carcinoma patients based on genomic aberrations
    Grimm, Julia
    Zeuschner, Philip
    Janssen, Martin
    Wagenpfeil, Stefan
    Hartmann, Arndt
    Stoehr, Christine
    Keck, Bastian
    Kahlmeyer, Andreas
    Stoeckle, Michael
    Junker, Kerstin
    GENES CHROMOSOMES & CANCER, 2019, 58 (09): : 612 - 618